---
figid: PMC5377799__zbc0151763870008
figtitle: Conceptual framework of CDKN2A expression during persistent LPS senescence
  induction
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5377799
filename: zbc0151763870008.jpg
figlink: /pmc/articles/PMC5377799/figure/F8/
number: F8
caption: Conceptual framework of CDKN2A expression during persistent LPS senescence
  induction. Persistent cholangiocyte stress results in the activation of NRAS and
  subsequently the MAPK/ERK signaling pathway. ETS1 is up-regulated, is phosphorylated,
  and translocates to the nucleus. In the nucleus, epigenetic histone modification
  (e.g. H3K4me3) allows p-ETS1 to bind to the CDKN2A promoter, resulting in CDKN2A
  transcription and, ultimately, cellular senescence. Pharmacologic inhibition of
  RAS/MEK/ERK (manumycin A, PD98059, or UO126) and suppression of ETS1 (ETS1-shRNA
  and genome editing) prevents CDKN2A transcription and senescence.
papertitle: ETS Proto-oncogene 1 Transcriptionally Up-regulates the Cholangiocyte
  Senescence-associated Protein Cyclin-dependent Kinase Inhibitor 2A.
reftext: Steven P. O'Hara, et al. J Biol Chem. 2017 Mar 24;292(12):4833-4846.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7332462
figid_alias: PMC5377799__F8
figtype: Figure
redirect_from: /figures/PMC5377799__F8
ndex: c3649567-df2e-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5377799__zbc0151763870008.html
  '@type': Dataset
  description: Conceptual framework of CDKN2A expression during persistent LPS senescence
    induction. Persistent cholangiocyte stress results in the activation of NRAS and
    subsequently the MAPK/ERK signaling pathway. ETS1 is up-regulated, is phosphorylated,
    and translocates to the nucleus. In the nucleus, epigenetic histone modification
    (e.g. H3K4me3) allows p-ETS1 to bind to the CDKN2A promoter, resulting in CDKN2A
    transcription and, ultimately, cellular senescence. Pharmacologic inhibition of
    RAS/MEK/ERK (manumycin A, PD98059, or UO126) and suppression of ETS1 (ETS1-shRNA
    and genome editing) prevents CDKN2A transcription and senescence.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRF6
  - NRAS
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - ETS1
  - CDKN2A
  - H3P10
  - ERVW-4
  - Manumycin H
  - UO126
---
